xBxBio Business Continuity, Disaster Recovery & Operational Resilience Policy
Effective Date: November 5, 2025
Last Updated: October 5, 2026
1. Purpose and Public Assurance
This policy establishes xBxBio's public-facing principles for business continuity, disaster recovery, operational resilience, backup, restoration, failover, degraded-mode operation, and recovery governance across the xBxBio ecosystem. Its purpose is to provide patients, clinicians, caregivers, healthcare organizations, laboratories, research organizations, customers, partners, regulators, and other authorized stakeholders with assurance that xBxBio treats continuity and recovery as governed lifecycle activities tied to patient safety, information integrity, security, privacy, quality, and responsible operations.
2. Public Disclosure Boundary
This is a governance and assurance policy, not an engineering specification. Public disclosure is intentionally limited to functional, clinical, quality, security, privacy, resilience, interoperability, regulatory, and governance principles. Detailed technical, operational, security, and customer-specific information is maintained separately in controlled internal documentation and is outside the scope of this public policy.
3. Scope
This policy applies, as appropriate, to current and future xBxBio modules, submodules, services, interfaces, data stores, analytical processes, AI-enabled functions, Virtual Heart functions, clinical and research workflows, development and validation environments, production environments, customer-facing services, and authorized third-party services used by or on behalf of xBxBio.
4. Technology-Neutral and Future-Capability Scope
The absence of a specific vendor, cloud, data center, device, modality, interface, deployment pattern, technology type, or jurisdiction from an illustrative list does not exclude that capability from this policy where it falls within the defined scope.
5. Continuity and Resilience Objectives
xBxBio seeks to preserve essential operations, protect patient and customer information, maintain clinical and scientific context, reduce disruption, enable orderly recovery, and restore affected capabilities in a controlled and evidence-supported manner. Recovery priorities are intended to reflect risk, patient impact, contractual obligations, operational dependencies, data integrity, and applicable legal or regulatory requirements.
6. Definitions and Interpretation
Business continuity refers to the capability to continue or restore essential operations during disruption. Disaster recovery refers to the coordinated restoration of technology, data, infrastructure, and dependent services. Operational resilience refers to the ability to prepare for, withstand, respond to, recover from, and learn from disruption while preserving essential outcomes.
7. Governance
Business continuity and disaster recovery activities should be subject to defined governance, assigned ownership, documented decision authority, review, evidence retention, and escalation appropriate to the affected service and risk.
8. Accountability
Human accountability is retained for continuity, recovery, failover, restoration, exception approval, risk acceptance, and return-to-service decisions. Automated recovery may support operations but does not eliminate accountable human oversight where judgment, safety, security, privacy, or regulatory obligations are involved.
9. Business Continuity Management Framework
xBxBio should maintain a continuity framework that integrates risk assessment, business impact analysis, recovery planning, backup and restoration, crisis communication, incident response, cybersecurity recovery, supplier continuity, testing, training, corrective action, and periodic review.
10. Business Impact Analysis
Business impact analysis should identify critical services, information, dependencies, recovery priorities, acceptable disruption windows, patient and customer impacts, operational consequences, and recovery resources appropriate to the maturity and intended use of each capability.
11. Critical Service Identification
Services should be categorized according to their importance to patient safety, clinical or scientific workflow, security, privacy, data integrity, customer operations, regulatory obligations, and platform dependencies. Criticality classifications may change as capabilities mature or intended use changes.
12. Critical Data Identification
Recovery planning should identify the data, configuration, metadata, provenance, audit information, and supporting records required to restore an affected service to an appropriate trustworthy state.
13. Recovery Prioritization
Recovery should be prioritized according to defined criticality, patient or user impact, dependency order, data integrity, security posture, operational need, contractual commitment, and applicable regulatory requirements rather than solely by technical convenience.
14. Dependency Management
Continuity planning should consider internal and external dependencies including identity services, networks, storage, databases, cloud services, APIs, device gateways, messaging, certificate services, DNS, monitoring, vendor platforms, support personnel, and other services necessary for safe restoration.
15. Patient Safety and Care Continuity
Where xBxBio capabilities may affect clinical workflows, continuity planning should consider patient safety, care-team awareness, availability of source evidence, escalation, alternative workflows, reconciliation after recovery, and prevention of misleading or stale information.
16. Clinical Downtime and Degraded Mode
Where appropriate, xBxBio should support defined downtime or degraded-mode behaviors that make system limitations visible, reduce unsafe assumptions, preserve available evidence, and support authorized users until normal service is restored.
17. Essential Operations
Essential operations should be identified in advance where reasonably possible so that personnel and systems can focus resources on the functions necessary to protect patients, information, security, legal obligations, and core service continuity.
18. Maximum Tolerable Period of Disruption
Where applicable, xBxBio should define or support determination of the maximum tolerable period of disruption for critical services based on intended use, customer requirements, patient impact, operational dependency, and risk.
19. Recovery Time Objectives
Recovery Time Objectives (RTOs), where defined, should express target restoration timeframes for services or capabilities. RTOs are planning and validation targets and should not be represented as absolute guarantees unless expressly established by contract or other binding commitment.
20. Recovery Point Objectives
Recovery Point Objectives (RPOs), where defined, should express target limits on acceptable data loss measured in time or another appropriate unit. RPOs should reflect data criticality, write frequency, technical architecture, and risk.
21. Service-Level Alignment
Continuity and recovery targets should be aligned, where applicable, with contractual service levels, customer requirements, supplier capabilities, and technical dependencies. Conflicts or gaps should be identified and managed rather than silently assumed away.
22. Resilience by Design
Resilience should be considered during architecture, development, deployment, change control, and operational planning, including failure modes, recoverability, observability, dependency isolation, safe degradation, and restoration evidence.
23. Redundancy
Redundancy may be used to reduce single points of failure where justified by risk and system design. Redundancy does not eliminate the need for backup, integrity verification, recovery testing, or documented failover procedures.
24. High Availability
High-availability mechanisms, where implemented, should be governed as resilience controls and evaluated for failure behavior, dependency assumptions, synchronization, data consistency, and recoverability.
25. Capacity and Resource Resilience
Continuity planning should consider compute, storage, network, licensing, workforce, supplier, and other capacity constraints that could prevent successful failover or recovery during elevated demand or disruption.
26. Backup Principles
Backups should be designed to support restoration of information and system state appropriate to defined recovery requirements. Backup existence alone is not considered sufficient evidence of recoverability.
27. Backup Coverage
Backup scope should consider, as applicable, databases, files, object stores, configurations, infrastructure definitions, audit records, metadata, patient-linked state, and other information necessary for controlled restoration.
28. Backup Frequency
Backup frequency should be risk-based and should consider data creation rates, RPO targets, operational criticality, technical feasibility, and the consequences of data loss.
29. Backup Retention
Backup retention should be governed according to recovery need, legal and regulatory requirements, contractual obligations, data lifecycle rules, storage risk, and authorized disposal requirements.
30. Immutable and Protected Recovery Copies
Where appropriate to risk, recovery design should include protected, immutable, logically isolated, offline, or otherwise resilient copies intended to reduce the effect of ransomware, destructive actions, corruption, or compromise of primary systems.
31. Geographic and Failure-Domain Separation
Where appropriate, recovery resources should be separated from primary resources by geographic region, availability zone, account, tenant, network, administrative boundary, or other failure domain sufficient to address the relevant risk.
32. Backup Encryption
Backup and recovery data should be protected in transit and at rest using controls appropriate to sensitivity, applicable law, customer commitments, and the operational environment.
33. Backup Access Control
Access to backup and recovery resources should be restricted to authorized roles and governed using appropriate identity, authentication, authorization, logging, and segregation-of-duties controls.
34. Backup Monitoring
Backup jobs and recovery resources should be monitored for failures, abnormal duration, capacity issues, corruption indicators, security events, and other conditions that could undermine recovery readiness.
35. Backup Integrity
Backup integrity should be assessed using appropriate technical and procedural controls so that corrupted, incomplete, maliciously altered, or otherwise untrustworthy recovery data are not assumed to be safe merely because a backup completed.
36. Restoration Testing
Restoration should be tested at a frequency and depth appropriate to risk. Testing should demonstrate that selected data and services can be restored into a usable and trustworthy state, not merely that backup files exist.
37. Restore Priorities
Restoration sequencing should reflect dependencies and service criticality. Foundational services such as identity, networking, databases, security controls, or data integrity mechanisms may require restoration before dependent clinical or analytical functions.
38. Configuration and Infrastructure Recovery
Recovery planning should consider approved system configurations, infrastructure definitions, dependencies, and documentation required to restore an authorized system state.
39. Keys, Secrets, and Certificates
Continuity planning should address the availability and secure recovery of cryptographic keys, certificates, secrets, service identities, and related trust material without exposing sensitive values in public documentation.
40. Audit and Provenance Recovery
Recovery should preserve or restore, as applicable, audit trails, data lineage, provenance, timestamps, version relationships, approvals, and other records needed to understand what occurred before, during, and after a disruption.
41. Patient and Clinical Data
Recovery of patient-linked information should preserve patient association, source identity, chronology, clinical context, provenance, and authorization boundaries to reduce the risk of misattribution, duplication, or unsafe interpretation.
42. Imaging, Waveform, and Physiologic Data
Where applicable, recovery planning should address large imaging objects, ECG and waveform data, device streams, derived measurements, synchronization metadata, and links to source systems so that restored information remains interpretable in context.
43. Laboratory, Genomic, and Molecular Data
Recovery planning should consider laboratory, genetic, genomic, and molecular data together with identifiers, source systems, result status, reference context, provenance, and applicable retention or access controls.
44. Virtual Heart and Patient-Specific Model Data
Where applicable, recovery planning should preserve patient linkage, source evidence, approved model state, provenance, uncertainty information, outputs, and validation context needed to distinguish restored patient-specific states from newly generated or superseded states.
45. AI and Machine-Learning Continuity
Recovery planning for AI-enabled functionality should consider approved versions, configuration, evaluation evidence, metadata, dependencies, monitoring state, and controls needed to avoid unintended substitution of unapproved components after recovery.
46. Databases, Object Stores, and File Systems
Recovery methods should reflect the consistency and transactional characteristics of each storage technology. Restoration should consider point-in-time relationships, referential integrity, version state, and dependencies among data stores.
47. Tenant and Customer Data Isolation
Multitenant recovery should preserve tenant boundaries and customer authorization. Recovery activity should not create unauthorized cross-tenant visibility, commingling, or access.
48. Cloud Resilience
Cloud deployments should account for shared-responsibility boundaries, regional or zone failures, service quotas, identity dependencies, provider recovery capabilities, backup portability, and the difference between provider availability features and customer-specific recovery obligations.
49. On-Premises and Hybrid Environments
Where xBxBio is deployed on-premises or in hybrid environments, continuity responsibilities should address customer infrastructure, network connectivity, local storage, identity, interfaces, environmental controls, and shared operational responsibilities.
50. Edge and Connected Device Continuity
Where applicable, edge services and connected-device workflows should consider temporary loss of connectivity, buffering, store-and-forward behavior, device state, time synchronization, source provenance, and safe reconciliation when communications resume.
51. Network Resilience
Continuity planning should consider loss or degradation of internet, private network, VPN, routing, firewall, load-balancing, DNS, and other connectivity services required for platform access or system integration.
52. Identity and Access Resilience
Recovery planning should address identity providers, multifactor authentication, authorization data, privileged access, emergency access, service accounts, and restoration of access controls before normal operation resumes.
53. Third-Party and Supplier Continuity
Critical suppliers and service providers should be evaluated according to their role, dependency, recovery capabilities, contractual obligations, security posture, and potential effect on xBxBio continuity. Supplier recovery assumptions should be reviewed rather than treated as guaranteed.
54. External Service Outage
Plans should consider the temporary or prolonged unavailability of external APIs, cloud services, communications providers, identity systems, data feeds, repositories, or vendor platforms and define appropriate degraded behavior or recovery actions where practical.
55. Facility, Power, and Environmental Disruption
Continuity planning should consider facility access, power loss, environmental hazards, cooling, fire, water, natural disaster, and other physical events where they are relevant to xBxBio-controlled or customer-
controlled infrastructure.
56. Workforce Continuity
Plans should consider loss or unavailability of key personnel, remote-work capability, succession or backup roles, escalation coverage, privileged operations, and preservation of critical knowledge necessary for recovery.
57. Telecommunications Continuity
Where operationally relevant, continuity planning should address voice, messaging, email, paging, conferencing, and other communication channels needed to coordinate response, customer support, and clinical or operational escalation.
58. Cybersecurity Event Recovery
Business continuity and disaster recovery should be coordinated with cybersecurity incident response. Restoration following a cyber event should consider containment, evidence preservation, credential compromise, persistence, integrity of backups, safe rebuild, and verification before return to service.
59. Ransomware
Ransomware preparedness should consider isolation, protected recovery copies, credential security, restoration sequencing, integrity validation, communication, forensic needs, and safe restoration without assuming compromised systems or backups are trustworthy.
60. Malware and Destructive Code
Recovery from malware or destructive code should include controls to reduce reinfection or reintroduction of malicious artifacts and should support validation of restored software, configuration, data, and credentials.
61. Data Corruption
Recovery planning should address logical and physical corruption, including corruption that propagates into replicas or backups. Detection, point-in-time recovery, integrity checks, and reconciliation should be used as appropriate to the affected technology.
62. Accidental Deletion or Misconfiguration
Plans should address accidental deletion, configuration error, unintended deployment, and other human or automated mistakes through versioning, backup, rollback, change records, and controlled restoration as appropriate.
63. Unauthorized Change
Recovery should distinguish legitimate change from unauthorized or malicious modification. Restored states should be verified against authorized configurations, versions, approvals, and integrity evidence where appropriate.
64. Insider-Related Disruption
Continuity and recovery controls should consider the possibility that an authorized account or insider action contributed to disruption, including the need for independent credentials, segregation of duties, protected logs, and alternate administrative paths.
65. Denial of Service and Resource Exhaustion
Plans should consider service degradation or unavailability caused by denial-of-service events, traffic surges, resource exhaustion, quota limits, or dependency saturation and should define appropriate protection, scaling, prioritization, or recovery actions.
66. Disaster Recovery Activation
Criteria for activating disaster recovery should be defined according to incident severity, service impact, safety, data integrity, expected duration, available alternatives, and decision authority. Activation should be documented where appropriate.
67. Crisis Management
Major disruptions should be managed through an appropriate command and coordination structure that integrates technical recovery, security, privacy, quality, clinical considerations, legal obligations, communications, and executive decision-making as needed.
68. Recovery Decision Authority
Roles authorized to declare a disruption, activate recovery, approve failover, accept temporary risk, restore service, and declare return to normal operations should be defined according to the affected environment and governance model.
69. Communications
Continuity plans should establish secure and reliable methods for communicating with personnel, customers, suppliers, and other stakeholders during disruption. Communications should be accurate, appropriately authorized, and limited to information suitable for the recipient.
70. Customer Communications
Where customer impact is material, xBxBio should provide appropriate status information consistent with contractual commitments, security needs, investigation integrity, legal obligations, and the maturity of available facts.
71. Regulatory, Privacy, and Legal Coordination
Disruptions involving personal data, protected health information, regulated systems, reportable events, safety concerns, or material contractual obligations should be evaluated for applicable notification, reporting, preservation, and legal requirements.
72. Emergency Contacts and Escalation
Continuity documentation should maintain appropriate contact and escalation information for internal roles, suppliers, customers, service providers, security resources, legal or regulatory support, and other authorized parties necessary for recovery.
73. Alternative Work Locations and Remote Operations
Where relevant, continuity planning should address secure remote work or alternate work locations, including access control, device security, communications, confidentiality, and availability of required tools and records.
74. Manual and Alternative Workflows
Where a technology service is unavailable, defined manual or alternative workflows may be used when appropriate, safe, authorized, and understood by affected users. Temporary alternatives should not obscure system limitations or bypass required controls without explicit authorization.
75. Read-Only and Restricted Modes
Where technically appropriate, a read-only or restricted operating mode may be used to preserve access to trustworthy information while preventing unsafe writes, automated actions, or state changes during partial service degradation.
76. Store-and-Forward and Buffered Data
Systems that buffer data during connectivity loss should preserve source identity, patient or session association, ordering, timestamps, provenance, and duplicate-detection information so that later reconciliation can occur safely.
77. Queued Transactions and Deferred Processing
Queued or deferred operations should be managed to prevent silent loss, unintended replay, duplicate processing, or execution in an obsolete context when normal service resumes.
78. Failover
Failover should be controlled, observable, and tested as appropriate. Failover procedures should consider data synchronization, identity, network paths, dependency readiness, user communication, and the possibility that the standby environment is not trustworthy or current.
79. Failback
Return from a recovery or secondary environment to the primary environment should be planned and controlled. Failback should address synchronization, data ownership, service interruption, validation, auditability, and rollback if the return is unsuccessful.
80. Post-Recovery Reconciliation
After restoration, xBxBio should reconcile data, events, transactions, alerts, tasks, interfaces, audit trails, and other affected state as appropriate to identify missing, duplicated, delayed, or conflicting information.
81. Duplicate and Replay Prevention
Recovery and reconnection processes should use controls appropriate to the workflow to reduce unintended duplicate records, duplicate actions, replayed transactions, or repeated clinical or operational notifications.
82. Temporal Integrity and Provenance
Recovery should preserve or reconstruct time relationships, source identity, version history, and provenance where these are necessary to understand the sequence and meaning of clinical, analytical, operational, or model-derived information.
83. Change Management
Changes that can affect continuity or recoverability should be evaluated under appropriate change control, including changes to architecture, interfaces, backup configuration, dependencies, deployment patterns, identity, data stores, and critical suppliers.
84. Rollback Capability
Where appropriate, deployments and configuration changes should support controlled rollback or other recovery methods when a change produces unacceptable behavior. Rollback should not be assumed safe if data schemas, irreversible migrations, or security conditions have changed.
85. Release and Deployment Recovery
Release procedures should consider failed deployment, partial deployment, incompatible components, database migration failure, dependency mismatch, and other scenarios that may require rollback, forward-fix, restoration, or controlled suspension.
86. Testing and Exercises
Continuity and recovery capabilities should be tested through a risk-based combination of technical tests, restoration tests, tabletop exercises, simulations, failover exercises, communications exercises, and other appropriate methods.
87. Tabletop Exercises
Tabletop exercises should evaluate decision-making, roles, communications, dependencies, escalation, patient or customer impact, and recovery priorities using plausible disruption scenarios.
88. Technical Failover Exercises
Where appropriate, technical exercises should demonstrate that services can transition to alternate resources and continue or resume operation within defined requirements without unacceptable loss of integrity, security, or control.
89. Restoration Exercises
Restoration exercises should verify that selected backups, configurations, and dependencies can be used to recreate an operational state and should identify gaps that are not apparent from backup-success indicators alone.
90. Cyber Recovery Exercises
Cyber recovery exercises should consider compromised credentials, malware persistence, backup integrity, rebuild from trusted sources, evidence preservation, isolation, and restoration of security controls before normal operations resume.
91. Supplier and Dependency Exercises
Where material dependencies exist, xBxBio should consider supplier continuity evidence, joint exercises, contractual recovery commitments, or other reasonable means of evaluating dependency resilience.
92. Evidence and Auditability
Continuity and recovery activities should produce appropriate evidence such as test records, restoration results, approvals, timestamps, incident records, change records, exceptions, corrective actions, and other documentation sufficient to support review and accountability.
93. Incident Review and Corrective Action
Material disruptions and significant exercises should be reviewed to identify root causes, contributing factors, control gaps, lessons learned, corrective and preventive actions, and opportunities to improve resilience.
94. Training and Awareness
Personnel with continuity or recovery responsibilities should receive training appropriate to their roles. General awareness should support prompt escalation, safe behavior during outages, protection of sensitive information, and adherence to authorized recovery procedures.
95. Metrics and Monitoring
xBxBio may use metrics appropriate to maturity and risk, including backup success, restoration success, recovery duration, recovery-point performance, failover readiness, unresolved continuity risks, exercise findings, and corrective-action closure.
96. Exceptions and Risk Acceptance
Exceptions to continuity, backup, or recovery requirements should be documented, risk-assessed, time-bounded where appropriate, approved by authorized personnel, and reviewed for compensating controls or remediation.
97. Continuous Improvement
Continuity and resilience controls should evolve based on incidents, exercises, architecture changes, customer needs, emerging threats, supplier changes, regulatory developments, and lessons learned.
98. Regulatory and Standards Alignment
This policy is intended to support, as applicable to xBxBio's role, intended use, deployment, jurisdiction, and contractual obligations, principles reflected in HIPAA contingency planning and security requirements; GDPR and UK GDPR security and availability obligations; applicable FDA medical-device and quality-system expectations; 21 CFR Part 11 where electronic records or signatures are within scope; applicable GxP and GAMP 5 principles; ISO 22301 business continuity management; ISO/IEC 27001-family information-security controls; NIST cybersecurity and recovery guidance; applicable Canadian federal or provincial privacy requirements; Japan's APPI and other applicable Japanese requirements; and other national, regional, state, provincial, or sector-specific requirements. References to standards or laws do not by themselves represent certification, approval, clearance, authorization, or universal applicability.
99. Research, Pre-Commercial, and Regulatory Status
Public statements about continuity or recovery should reflect the actual development and deployment status of the relevant xBxBio capability. This policy does not represent FDA clearance or approval, clinical validation, regulatory authorization, independent certification, guaranteed availability, or guaranteed recovery performance unless separately and specifically established.
100. Public Information Boundary
This public policy is limited to governance and assurance principles. Nonpublic technical, security, customer, and operational information is maintained in controlled internal documentation and is not included in this public policy.
101. Customer and Shared Responsibilities
Continuity responsibilities may be shared among xBxBio, customers, cloud or infrastructure providers, device or interface vendors, and other authorized parties. Specific responsibilities depend on deployment model, contract, configuration, intended use, and operational control and should be defined rather than assumed.
102. Human Oversight and Safe Return to Service
Return to service should occur only after appropriate verification that affected capabilities are sufficiently stable, secure, available, and trustworthy for the intended use. Where clinical or safety-relevant functions are involved, restoration should not be treated as equivalent to clinical validation or authorization for unrestricted use.
103. Records and Document Control
Policies, plans, test records, recovery evidence, exceptions, approvals, and corrective actions should be maintained under document and record controls appropriate to their purpose, sensitivity, retention requirement, and regulatory relevance.
104. Policy Review
This policy should be reviewed periodically and following significant changes in xBxBio services, deployment patterns, patient or clinical functions, infrastructure, suppliers, major incidents, regulatory requirements, or business continuity risk.
105. Global Protection Statement
No country, territory, customer configuration, deployment model, facility, technical environment, interface, vendor, cloud provider, or contractual arrangement is intended to eliminate xBxBio's fundamental requirements for patient protection, human accountability, authorized access, information integrity, provenance, privacy, security, responsible recovery, quality, and appropriate governance. A country or territory does not need to be individually named in this public policy for the global baseline to apply where xBxBio lawfully conducts relevant activities.
END OF XBXBIO BUSINESS CONTINUITY, DISASTER RECOVERY & OPERATIONAL RESILIENCE POLICY